Table 2.
Shapiro–Wilk test.
| Variable | Skewness | Kurtosis | SE | W | p |
|---|---|---|---|---|---|
| Age | −0.414 | 0.320 | 0.662 | 0.983 | 0.000 |
| T | 3.030 | 17.773 | 0.022 | 0.749 | 0.000 |
| P | 0.716 | 1.573 | 0.842 | 0.972 | 0.000 |
| R | 1.455 | 4.777 | 0.165 | 0.830 | 0.000 |
| eGFR | −0.675 | 0.346 | 1.709 | 0.931 | 0.000 |
| WBC | 1.049 | 1.395 | 0.208 | 0.936 | 0.000 |
| HB | −0.857 | 3.439 | 1.223 | 0.953 | 0.000 |
| PLT | 0.529 | 1.423 | 3.676 | 0.977 | 0.000 |
| Time from on set to CT | 0.790 | −0.785 | 0.366 | 0.859 | 0.000 |
| V2 | 1.876 | 4.057 | 1.570 | 0.789 | 0.000 |
| V | 1.992 | 5.034 | 1.262 | 0.792 | 0.000 |
| HII | 0.710 | −0.765 | 0.412 | 0.892 | 0.000 |
| GCS | −0.837 | −0.649 | 0.188 | 0.847 | 0.000 |
| ALT | 12.726 | 204.080 | 1.775 | 0.316 | 0.000 |
| TT | 0.428 | 3.539 | 0.074 | 0.956 | 0.000 |
| AST | 4.250 | 23.479 | 1.211 | 0.578 | 0.000 |
| DD | 9.843 | 132.546 | 0.204 | 0.314 | 0.000 |
| INR | 5.475 | 42.852 | 0.008 | 0.582 | 0.000 |
| APTT | 6.956 | 91.449 | 0.228 | 0.646 | 0.000 |
| FIB | 1.633 | 4.867 | 0.058 | 0.885 | 0.000 |
| PH | −0.871 | 6.828 | 0.003 | 0.926 | 0.000 |
| Lactate | 4.253 | 28.666 | 0.077 | 0.659 | 0.000 |
| PO2 | 1.481 | 7.491 | 1.780 | 0.922 | 0.000 |
| PCO2 | 1.763 | 17.462 | 0.364 | 0.873 | 0.000 |
| BMI | 0.542 | 5.946 | 0.158 | 0.926 | 0.000 |
T, Temperature; P, Pulse; R, Respiration; eGFR, estimated glomerular filtration rate; WBC, white blood cell; Hb, hemoglobin; PLT, platelet; V, hematoma volume; V2, secondary hematoma volume; HII, Hemorrhage Heterogeneity Index; GCS, Glasgow Coma Scale; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TT, thrombin time; DD, D-dimer; INR, international normalized ratio; APTT, activated partial thromboplastin time; FIB, fibrinogen; pH, potential of hydrogen; Lactate, blood lactate; PO₂, partial pressure of oxygen; PCO₂, partial pressure of carbon dioxide; BMI, body mass index.